1. Home
  2. CRBP vs CBFV Comparison

CRBP vs CBFV Comparison

Compare CRBP & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CRBP

Corbus Pharmaceuticals Holdings Inc.

N/A

Current Price

$4.12

Market Cap

190.3M

Sector

Health Care

ML Signal

N/A

Logo CB Financial Services Inc.

CBFV

CB Financial Services Inc.

N/A

Current Price

$39.17

Market Cap

189.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CRBP
CBFV
Founded
2009
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
190.3M
189.9M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
CRBP
CBFV
Price
$4.12
$39.17
Analyst Decision
Strong Buy
Buy
Analyst Count
10
3
Target Price
$34.89
★ $42.67
AVG Volume (30 Days)
★ 860.0K
3.0K
Earning Date
11-11-2026
10-26-2026
Dividend Yield
N/A
★ 2.79%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 1.54
Revenue
$4,822,272.00
★ $43,557,000.00
Revenue This Year
N/A
$15.58
Revenue Next Year
$131.00
$8.97
P/E Ratio
★ N/A
$26.06
Revenue Growth
★ 97.62
N/A
52 Week Low
$3.87
$31.72
52 Week High
$12.88
$40.39

Technical Indicators

Market Signals
Indicator
CRBP
CBFV
Relative Strength Index (RSI) 24.53 66.11
Support Level N/A $35.71
Resistance Level $8.13 N/A
Average True Range (ATR) 0.32 0.71
MACD 0.11 0.26
Stochastic Oscillator 18.76 88.60

Price Performance

Historical Comparison
CRBP
CBFV

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About CBFV CB Financial Services Inc.

CB Financial Services Incis a bank holding company headquartered in Carmichaels, Pennsylvania. The company had one reportable segment, community banking services. The Bank also has a loan production office in Allegheny County, a loan production office and a corporate center in Washington County, and an operations center in Greene County, Pennsylvania. The Bank is a community-oriented institution offering residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a variety of deposit products for individuals and businesses in its market area.

Share on Social Networks: